Open menu

Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

Posted: Jun 13, 2011

Microfluidics Establishes PureNano Group to Advance Continuous Manufacturing of Nanomaterials

(Nanowerk News) Microfluidics, the exclusive global provider of Microfluidizer® high shear fluid processors, today launched a dedicated, internal PureNano Group (PNG) to develop go-to-market strategies for PureNano. This is an exclusive, award-winning, processing technology used to create tailored nanomaterials through crystallization, chemical reaction and nano-encapsulation. Applications of the technology include nanotechnology- based novel pharmaceuticals, functional foods and catalysts.
"Our PureNano Technology is a leap forward for materials engineering in producing the purest, most uniform nano-sized substances available anywhere," said Thomai (Mimi) Panagiotou, Ph.D., Microfluidics Chief Technology Officer. "The PNG has the passion and commitment to advance PureNano's technology, process consulting, training and implementations. I am confident that we will achieve new levels of product quality and process efficiency for the pharmaceutical market, the energy industry and beyond."
Dr. Panagiotou will head the group. The PNG team will also include: MIT Chemical Engineering senior faculty member Robert J. Fisher, Ph.D., PureNano Engineering Manager Ken Chomistek and Microfluidics Global Sales Support Manager Tom Speed.
Over the next six months PNG's business objectives will include
  • Establishing PureNano customer interactions, services and implementation
  • Assuring that each PureNano unit is implemented successfully
  • Creating market knowledge about the technology's capabilities
  • Developing and integrating a comprehensive sales training module
  • PureNano Technology
    PureNano Technology, a cutting-edge platform for continuous manufacturing, combines a unique, high shear fluid processor with expert process development. It is a revolutionary technology for bottom-up nanoparticle creation offering:
  • Continuous crystallization for production of highly crystalline drug nanoparticles
  • Multi-phase chemical reactions
  • Nanoencapsulation of actives
  • Process intensification
  • With the goal of reducing the time and cost of commercial drug formulation, PureNano enables companies to transform their batch manufacturing efforts into continuous production processes. Through the bottom-up creation of nanoparticles, as well as the ability to control their growth, PureNano enables research teams to develop stable and consistent nanoemulsions of previously unattainable sizes and narrow distributions (such as Azithromycin with a z-average particle size of 82 nm).
    About Microfluidics
    Microfluidics, an IDEX company, is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, robust cell disruption and bottom-up nanoparticle creation. Used primarily by pharmaceutical, biotechnology, chemical, cosmetic, nutraceutical/food and energy companies to research, develop and improve products with efficient processes, more than 3,000 Microfluidizer processors are installed at customer sites in 50 countries around the world. The innovative MicrofluidicsTechnologyCenter, located at the company's headquarters outside Boston, Mass., is staffed by expert engineers with a wide range of nanotechnology and application experience for Proof of Concept and Process Development services.
    By producing smaller particle sizes and a more narrow distribution than other technologies, with scaleup from lab to production guaranteed, Microfluidics enables companies to create tiny particles that achieve big results. To learn more, visit
    Source: Microfluidics (press release)
    Subscribe to a free copy of one of our daily
    Nanowerk Newsletter Email Digests
    with a compilation of all of the day's news.
    If you liked this article, please give it a quick review on reddit or StumbleUpon. Thanks!
    These articles might interest you as well: